Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients

Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies

(2016) D.M.W. Balak et al.   BRITISH JOURNAL OF DERMATOLOGY

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

(2016) Antonios G.A. Kolios et al.   DERMATOLOGY

Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression

(2016) Jessie Grewal et al.   JOURNAL OF NEUROVIROLOGY

Progressive multifocal leukoencephalopathy in an immunocompetent patient

(2016) Nicolien M. van der Kolk et al.   Annals of Clinical and Translational Neurology

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

(2015) K. Reich et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate

(2015) Nele Dammeier et al.   BMC Neurology

Immunology of progressive multifocal leukoencephalopathy

(2015) Ivan Jelcic et al.   JOURNAL OF NEUROVIROLOGY

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

(2015) A. Nast et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

PML in Patients Treated with Dimethyl Fumarate

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate

(2015) Dennis J. Nieuwkamp et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate

(2015) Thorsten Rosenkranz et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk

(2015) Bhupendra O. Khatri et al.   Multiple Sclerosis and Related Disorders

Regulated genes in psoriatic skin during treatment with fumaric acid esters

(2014) A.J. Onderdijk et al.   BRITISH JOURNAL OF DERMATOLOGY

Drug survival of fumaric acid esters for psoriasis: a retrospective study

(2014) N. Ismail et al.   BRITISH JOURNAL OF DERMATOLOGY

Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis

(2014) Muriel Stoppe et al.   JOURNAL OF NEUROLOGY

A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy

(2014) Salim Chahin et al.   JOURNAL OF NEUROVIROLOGY

Newer agents for psoriasis in adults

(2014) Z. K. Jabbar-Lopez et al.   BMJ-British Medical Journal

Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists

(2013) S. Fallah Arani et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy

(2013) Bob W. van Oosten et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient Treated with Fumaric Acid

(2013) Ummehan Ermis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Case Reports of PML in Patients Treated for Psoriasis

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions

(2012) M. Inzinger et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

(2009) D Pathirana et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY